Healthcare Industry News:  hyperthermia therapy 

Devices Oncology Radiology

 News Release - July 31, 2009

BSD Medical Hyperthermia System Integrated with GE Healthcare MR System at Duke University School of Medicine

SALT LAKE CITY, July 31--(HSMN NewsFeed)--BSD Medical Corporation (NASDAQ: BSDM ) (www.bsdmedical.com) announced today that the Company has completed integration of a BSD-2000/3D/MR Hyperthermia System with a GE Healthcare (GE) 1.5 Tesla magnetic resonance (MR) imaging system at the Duke Comprehensive Cancer Center at Duke University Medical Center. GE Healthcare is a division of the General Electric Company. This is the first installation in the United States of the BSD-2000/3D/MR and the first integration of a BSD-2000/3D/MR system with a GE MR system. The integration and installation was a joint effort between BSD Medical, Duke University, and GE Healthcare engineers, physicists, and physicians.

The BSD-2000 system, which was invented by BSD Medical, delivers energy that can be electronically focused to target the 3-dimensional shape, size, and location of the tumor, thus providing dynamic control of the heating delivered to the tumor region. The BSD-2000/3D/MR system integrates a BSD-2000/3D Hyperthermia System with an MR system. The integrated system was designed to deliver targeted hyperthermia therapy while simultaneously providing non-invasive imaging of the diseased tissue as well as the surrounding healthy tissue. Duke University is a world leader in the development of non-invasive imaging techniques for hyperthermia using MR imaging.

About Duke University Medical Center

Duke University Medical Center is one of 40 centers in the US that has been designated by the National Cancer Institute (NCI) as a “comprehensive cancer center.” Duke is known for its cutting-edge research. The Duke Comprehensive Cancer Center is ranked as one of the top 10 cancer hospitals in the country, according to U.S. News & World Report's "America's Best Hospitals" survey.

About BSD Medical Corporation

BSD Medical’s product line includes systems that have been strategically designed to offer a range of thermal treatment locations and indications. BSD Medical is the leading developer of hyperthermia systems. The BSD-2000 Hyperthermia System is currently restricted to investigational use in the United States. For further information visit BSD Medical's website at www.bsdmedical.com.

Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.


Source: BSD Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.